Genomics

Dataset Information

0

LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE71298 | GEO | 2015/10/01

SECONDARY ACCESSION(S): PRJNA290856

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer.
| S-EPMC4791209 | biostudies-literature
Unknown LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer [array]
2015-10-01 | GSE71297 | GEO
Unknown LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer [ChIP-Seq]
2015-10-01 | GSE71276 | GEO
Unknown Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer.
| S-EPMC8433133 | biostudies-literature
Unknown HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer.
| S-EPMC8210559 | biostudies-literature
Unknown Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.
| S-EPMC7961649 | biostudies-literature
Unknown ?EF1 down-regulates ER-? expression and confers tamoxifen resistance in breast cancer.
| S-EPMC3528679 | biostudies-literature
Unknown Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
| S-EPMC7655217 | biostudies-literature
Unknown The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells.
| S-EPMC7150441 | biostudies-literature
Unknown COPS5 amplification and overexpression confers tamoxifen-resistance in ER?-positive breast cancer by degradation of NCoR.
| S-EPMC4932188 | biostudies-literature